OBJECTIVEdGroup medical clinics (GMC) combine medication management and self-management training, and may improve diabetes outcomes. It remains unclear which patients benefit most from GMC. This secondary analysis examined the impact of baseline insulin reg-imen on GMC response. RESEARCHDESIGNANDMETHODSdWe analyzed a trial of 239 veterans with type 2 diabetes randomized to GMC or usual care (UC). We categorized baseline insulin regimen as the following: no insulin; basal insulin only; or complex insulin (basal–prandial or mixed regimens). Using linear mixed models adjusted for clustering within GMC, we evaluated the differential impact of GMC relative to UC on hemoglobin A1c (HbA1c) and self-efficacy among patients on different baseline ins...
Aim. To compare the efficiency of standard and structured approaches to self-monitoring of blood ...
Aims To identify HbA1c trajectories after the start of insulin treatment and to identify clinically ...
We compared cardiovascular and other outcomes in patients with dysglycaemia with or without anti‐glu...
OBJECTIVEGroup medical clinics (GMC) combine medication management and self-management training, and...
This case-control study was designed to analyse predictors of the effects on HbA1c levels in 4001 ty...
Abstract OBJECTIVE: The SOLVE study investigated the initiation of basal insulin in patients with ty...
Aims/Introduction: We investigated the association between four insulin regimens, and increase in gl...
BACKGROUND: When target glycated hemoglobin (HbA1C) levels are not reached, basal insulin therapy sh...
BACKGROUND: The purpose of this study was to compare diabetes (DM)-related outcomes between basal-bo...
AIMS: To identify HbA1c trajectories after the start of insulin treatment and to identify clinically...
Background: Pharmacological and clinical differences between insulin glargine and NPH insulin may tr...
International audienceAims We performed a meta-analysis of randomized controlled trials with insulin...
AIMS: To evaluate factors associated with reaching or not reaching target glycated haemoglobin (HbA1...
Basal insulin treatment for type 2 diabetes is usually initiated on a background of oral glucose-low...
Objective: To evaluate hospitalized type 2 diabetes mellitus (T2DM) patients with dissimilar insulin...
Aim. To compare the efficiency of standard and structured approaches to self-monitoring of blood ...
Aims To identify HbA1c trajectories after the start of insulin treatment and to identify clinically ...
We compared cardiovascular and other outcomes in patients with dysglycaemia with or without anti‐glu...
OBJECTIVEGroup medical clinics (GMC) combine medication management and self-management training, and...
This case-control study was designed to analyse predictors of the effects on HbA1c levels in 4001 ty...
Abstract OBJECTIVE: The SOLVE study investigated the initiation of basal insulin in patients with ty...
Aims/Introduction: We investigated the association between four insulin regimens, and increase in gl...
BACKGROUND: When target glycated hemoglobin (HbA1C) levels are not reached, basal insulin therapy sh...
BACKGROUND: The purpose of this study was to compare diabetes (DM)-related outcomes between basal-bo...
AIMS: To identify HbA1c trajectories after the start of insulin treatment and to identify clinically...
Background: Pharmacological and clinical differences between insulin glargine and NPH insulin may tr...
International audienceAims We performed a meta-analysis of randomized controlled trials with insulin...
AIMS: To evaluate factors associated with reaching or not reaching target glycated haemoglobin (HbA1...
Basal insulin treatment for type 2 diabetes is usually initiated on a background of oral glucose-low...
Objective: To evaluate hospitalized type 2 diabetes mellitus (T2DM) patients with dissimilar insulin...
Aim. To compare the efficiency of standard and structured approaches to self-monitoring of blood ...
Aims To identify HbA1c trajectories after the start of insulin treatment and to identify clinically ...
We compared cardiovascular and other outcomes in patients with dysglycaemia with or without anti‐glu...